Cargando…
Systematic Review of Efficacy and Safety of Newer Antidiabetic Drugs Approved from 2013 to 2017 in Controlling HbA1c in Diabetes Patients
Type 2 Diabetes Mellitus (T2DM) is the most common form of diabetes mellitus and accounts for about 95% of all diabetes cases. Many newer oral as well as parenteral antidiabetic drugs have been introduced in to the market in recent years to control hyperglycemic conditions in diabetes patients and m...
Autores principales: | Palanisamy, Sivanandy, Yien, Emily Lau Hie, Shi, Ling Wen, Si, Low Yi, Qi, See Hui, Ling, Laura Soon Cheau, Lun, Teng Wai, Chen, Yap Nee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6164486/ https://www.ncbi.nlm.nih.gov/pubmed/29954090 http://dx.doi.org/10.3390/pharmacy6030057 |
Ejemplares similares
-
Red carpeting the newer antidiabetics
por: Gude, Dilip
Publicado: (2012) -
Newer antidiabetic drugs and calorie restriction mimicry
por: Kalra, Sanjay, et al.
Publicado: (2016) -
Longitudinal Modeling of the Relationship Between Mean Plasma Glucose and HbA1c Following Antidiabetic Treatments
por: Møller, J B, et al.
Publicado: (2013) -
Measurement of HbA(1c) and HbA(2) by Capillarys 2 Flex Piercing HbA(1c) programme for simultaneous management of diabetes and screening for thalassemia
por: Ke, Peifeng, et al.
Publicado: (2017) -
Standardization of the HbA(2) Assay
por: Paleari, Renata, et al.
Publicado: (2018)